carmustine has been researched along with Lymphoma, Large-Cell, Anaplastic in 6 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Lymphoma, Large-Cell, Anaplastic: A systemic, large-cell, non-Hodgkin, malignant lymphoma characterized by cells with pleomorphic appearance and expressing the CD30 ANTIGEN. These so-called hallmark cells have lobulated and indented nuclei. This lymphoma is often mistaken for metastatic carcinoma and MALIGNANT HISTIOCYTOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Quintana-Sancho, A | 1 |
| Acebo-Mariñas, E | 1 |
| Gardeazabal-García, J | 1 |
| Aperribay-Esparza, A | 1 |
| Zinno, F | 1 |
| Landi, F | 1 |
| Aureli, V | 1 |
| Cometa, AM | 1 |
| Scerpa, MC | 1 |
| Caniglia, M | 1 |
| Pinto, RM | 1 |
| Rana, I | 1 |
| Balduino, G | 1 |
| Miele, MJ | 1 |
| Isacchi, G | 1 |
| Foyil, KV | 1 |
| Kennedy, DA | 1 |
| Grove, LE | 1 |
| Bartlett, NL | 1 |
| Cashen, AF | 1 |
| Ordemann, R | 1 |
| Stöhlmacher, J | 1 |
| Beuthien-Baumann, B | 1 |
| Platzek, I | 1 |
| van den Hoff, J | 1 |
| Kroschinsky, F | 1 |
| Middeke, JM | 1 |
| Platzbecker, U | 1 |
| Zietz, C | 1 |
| Bornhäuser, M | 1 |
| Ehninger, G | 1 |
| Annaloro, C | 1 |
| Robbiolo, L | 1 |
| Pozzoli, E | 1 |
| Ibatici, A | 1 |
| Nicolini, A | 1 |
| Salerno, F | 1 |
| Deliliers, GL | 1 |
| Fanin, R | 1 |
| Silvestri, F | 1 |
| Geromin, A | 1 |
| Cerno, M | 1 |
| Infanti, L | 1 |
| Zaja, F | 1 |
| Barillari, G | 1 |
| Savignano, C | 1 |
| Rinaldi, C | 1 |
| Damiani, D | 1 |
| Baccarani, M | 1 |
6 other studies available for carmustine and Lymphoma, Large-Cell, Anaplastic
| Article | Year |
|---|---|
Cerebral involvement as the first extracutaneous manifestation of mycosis fungoides.
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Brain; Carmusti | 2015 |
Immunomagnetic selection of CD34(+) cells carried out in cryopreserved cell concentrates from a paediatric patient affected with non-Hodgkin lymphoma.
Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Preservation; Carmustine; Cell | 2010 |
Extended retreatment with brentuximab vedotin (SGN-35) maintains complete remission in patient with recurrent systemic anaplastic large-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Carmustine; Clinical Tri | 2012 |
Use of targeted therapy for refractory ALK-positive anaplastic large cell lymphoma as a bridging strategy prior to allogeneic transplantation.
Topics: Adult; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedot | 2013 |
Four-year survival after trans-jugular intrahepatic porto-systemic shunt for veno-occlusive disease following autologous bone marrow transplantation.
Topics: Adult; Carmustine; Combined Modality Therapy; Cyclophosphamide; Etoposide; Hemodynamics; Hepatic Ven | 2004 |
Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults.
Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosp | 1997 |